Monoclonal Antibody Infusion Kit for Rheumatoid Arthritis

This kit contains rituximab, a monoclonal antibody, pre-filled in measured-dose syringes for intravenous infusion to treat rheumatoid arthritis. It qualifies under HTS 3002.15.00.91 as an immunological product (peptide/protein regulating immunological processes) put up in measured doses for retail sale. Biotechnologically produced and modified for therapeutic use.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFreeFree
🇲🇽MexicoFreeFree
🇨🇦CanadaFreeFree
🇩🇪GermanyFreeFree
🇯🇵JapanFreeFree

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3002.12.00Same rate: Free

If not in measured doses or retail packing

Bulk immunological products without retail packaging fall under antisera/blood fractions, not retail forms.

2937.90Higher: 10% vs Free

If classified as hormones rather than immunological peptides

Certain biotech peptides may shift to hormones chapter if not directly regulating immunology per Chapter 30 notes.

3004.90Higher: 10% vs Free

If put up as medicaments in measured doses but not purely immunological

Mixed therapeutic preparations not exclusively immunological products classify under Chapter 30 heading 3004.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Maintain strict cold chain documentation (2-8°C) with temperature logs to prevent spoilage claims at customs

Provide FDA approval letters and biotech production certificates; misclassification as non-immunological risks penalties

Declare exact measured doses per package; retail packing distinguishes from bulk under 3002.10

Related Products under HTS 3002.15.00.91

Interferon Beta-1a Injection for Multiple Sclerosis

Prefilled syringes of recombinant interferon beta-1a, an immunological protein for modulating immune response in MS patients, packaged in retail-ready measured doses. Falls under HTS 3002.15.00.91 per chapter notes defining immunological products as proteins like interferons in retail forms.

Adalimumab Prefilled Syringe for Psoriasis Treatment

Humira-brand adalimumab, a TNF inhibitor monoclonal antibody in 40mg prefilled syringes for retail sale, used prophylactically against autoimmune psoriasis flares. Classified in HTS 3002.15.00.91 as a biotechnological immunological product in measured retail doses.

Interleukin-2 Injection for Melanoma Therapy

Recombinant human IL-2 in single-dose vials for retail, an immunological cytokine stimulating T-cell response in cancer immunotherapy. HTS 3002.15.00.91 applies as it matches chapter note for interleukins as immunological products in measured retail packs.

Bevacizumab Biosimilar Vial for Oncology

Avastin biosimilar bevacizumab, a VEGF monoclonal antibody in 100mg/4ml vials for retail infusion in cancer treatment, modulating angiogenesis via immune regulation. Fits HTS 3002.15.00.91 for MAB immunological products in measured doses.

Denosumab Injection for Osteoporosis

Prolia-brand denosumab, RANKL inhibitor antibody in 60mg prefilled syringes for retail, preventing bone resorption through immunological modulation. HTS 3002.15.00.91 for antibody-based immunological products in retail measured forms.